Fractional Exhaled Nitric Oxide Measurements in Rhinitis and Asthma in Children

Miraglia M. Del Giudice; G. L. Marseglia; S. Leonardi; M. A. Tosca; A. Marseglia; L. Perrone; G. Ciprandi

doi:10.1177/03946320110240S407

Fractional Exhaled Nitric Oxide Measurements in Rhinitis and Asthma in Children

Miraglia M. Del Giudice, G. L. Marseglia, S. Leonardi, M. A. Tosca, A. Marseglia, L. Perrone, G. Ciprandi

Research output: Contribution to journal › Article › peer-review

Abstract

Exaled nitric oxide (FeNO) is considered a good noninvasive marker to assess airway inflammation in asthma and allergic rhinitis. In asthma, exhaled NO is very useful to verify adherence to therapy, and to predict upcoming asthma exacerbations. It has been also proposed that adjusting anti-inflammatory drugs guided by the monitoring of exhaled NO, could improve overall asthma control. Other studies showed increased FeNO levels in subjects with allergic rhinitis.

Original language	English
Pages (from-to)	29-32
Number of pages	4
Journal	International Journal of Immunopathology and Pharmacology
Volume	24
DOIs	https://doi.org/10.1177/03946320110240S407
Publication status	Published - Oct 1 2011

Keywords

allergic rhinitis
asthma
fractional exhaled nitric oxide and children

ASJC Scopus subject areas

Pharmacology
Immunology
Immunology and Allergy

Access to Document

10.1177/03946320110240S407

Fingerprint Dive into the research topics of 'Fractional Exhaled Nitric Oxide Measurements in Rhinitis and Asthma in Children'. Together they form a unique fingerprint.

Cite this

@article{4899c2ce2627445fa3c8ef63db543161,

title = "Fractional Exhaled Nitric Oxide Measurements in Rhinitis and Asthma in Children",

abstract = "Exaled nitric oxide (FeNO) is considered a good noninvasive marker to assess airway inflammation in asthma and allergic rhinitis. In asthma, exhaled NO is very useful to verify adherence to therapy, and to predict upcoming asthma exacerbations. It has been also proposed that adjusting anti-inflammatory drugs guided by the monitoring of exhaled NO, could improve overall asthma control. Other studies showed increased FeNO levels in subjects with allergic rhinitis.",

keywords = "allergic rhinitis, asthma, fractional exhaled nitric oxide and children",

author = "{Del Giudice}, {Miraglia M.} and Marseglia, {G. L.} and S. Leonardi and Tosca, {M. A.} and A. Marseglia and L. Perrone and G. Ciprandi",

year = "2011",

month = oct,

day = "1",

doi = "10.1177/03946320110240S407",

language = "English",

volume = "24",

pages = "29--32",

journal = "International Journal of Immunopathology and Pharmacology",

issn = "0394-6320",

publisher = "Biomedical Research Press s.a.s.",

}

TY - JOUR

T1 - Fractional Exhaled Nitric Oxide Measurements in Rhinitis and Asthma in Children

AU - Del Giudice, Miraglia M.

AU - Marseglia, G. L.

AU - Leonardi, S.

AU - Tosca, M. A.

AU - Marseglia, A.

AU - Perrone, L.

AU - Ciprandi, G.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Exaled nitric oxide (FeNO) is considered a good noninvasive marker to assess airway inflammation in asthma and allergic rhinitis. In asthma, exhaled NO is very useful to verify adherence to therapy, and to predict upcoming asthma exacerbations. It has been also proposed that adjusting anti-inflammatory drugs guided by the monitoring of exhaled NO, could improve overall asthma control. Other studies showed increased FeNO levels in subjects with allergic rhinitis.

AB - Exaled nitric oxide (FeNO) is considered a good noninvasive marker to assess airway inflammation in asthma and allergic rhinitis. In asthma, exhaled NO is very useful to verify adherence to therapy, and to predict upcoming asthma exacerbations. It has been also proposed that adjusting anti-inflammatory drugs guided by the monitoring of exhaled NO, could improve overall asthma control. Other studies showed increased FeNO levels in subjects with allergic rhinitis.

KW - allergic rhinitis

KW - asthma

KW - fractional exhaled nitric oxide and children

UR - http://www.scopus.com/inward/record.url?scp=84856392176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856392176&partnerID=8YFLogxK

U2 - 10.1177/03946320110240S407

DO - 10.1177/03946320110240S407

M3 - Article

C2 - 22032784

AN - SCOPUS:84856392176

VL - 24

SP - 29

EP - 32

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

ER -